| Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics SA Polyzos, J Kountouras, CS Mantzoros Metabolism 92, 82-97, 2019 | 1144 | 2019 |
| Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. J Kountouras, BH Billing, PJ Scheuer British journal of experimental pathology 65 (3), 305, 1984 | 912 | 1984 |
| Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines SA Polyzos, J Kountouras, C Zavos Current molecular medicine 9 (3), 299-314, 2009 | 418 | 2009 |
| Adipokines in nonalcoholic fatty liver disease SA Polyzos, J Kountouras, CS Mantzoros Metabolism 65 (8), 1062-1079, 2016 | 390 | 2016 |
| Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis SA Polyzos, KA Toulis, DG Goulis, C Zavos, J Kountouras Metabolism 60 (3), 313-326, 2011 | 375 | 2011 |
| The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease SA Polyzos, J Kountouras, C Zavos, E Tsiaousi Diabetes, Obesity and Metabolism 12 (5), 365-383, 2010 | 364 | 2010 |
| The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related … VG Athyros, TK Alexandrides, H Bilianou, E Cholongitas, M Doumas, ... Metabolism 71, 17-32, 2017 | 316 | 2017 |
| The Association Between Helicobacter pylori Infection and Insulin Resistance: A Systematic Review SA Polyzos, J Kountouras, C Zavos, G Deretzi Helicobacter 16 (2), 79-88, 2011 | 303 | 2011 |
| Irisin in metabolic diseases SA Polyzos, AD Anastasilakis, ZA Efstathiadou, P Makras, N Perakakis, ... Endocrine 59, 260-274, 2018 | 282 | 2018 |
| Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis SA Polyzos, KN Aronis, J Kountouras, DD Raptis, MF Vasiloglou, ... Diabetologia 59, 30-43, 2016 | 274 | 2016 |
| Irisin in patients with nonalcoholic fatty liver disease SA Polyzos, J Kountouras, AD Anastasilakis, EV Geladari, CS Mantzoros Metabolism 63 (2), 207-217, 2014 | 267 | 2014 |
| Leptin in nonalcoholic fatty liver disease: a narrative review SA Polyzos, J Kountouras, CS Mantzoros Metabolism 64 (1), 60-78, 2015 | 263 | 2015 |
| Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease J Kountouras, M Boziki, E Gavalas, C Zavos, N Grigoriadis, G Deretzi, ... Journal of neurology 256, 758-767, 2009 | 246 | 2009 |
| Liver regeneration after hepatectomy. J Kountouras, P Boura, NJ Lygidakis Hepato-gastroenterology 48 (38), 556-562, 2001 | 246 | 2001 |
| Adipose tissue, obesity and non-alcoholic fatty liver disease. SA Polyzos, J Kountouras, CS Mantzoros Minerva endocrinologica 42 (2), 92-108, 2016 | 228 | 2016 |
| Extragastric Diseases and Helicobacter pylori F Franceschi, A Gasbarrini, SA Polyzos, J Kountouras Helicobacter 20, 40-46, 2015 | 205 | 2015 |
| Endoscopic techniques and management of foreign body ingestion and food bolus impaction in the upper gastrointestinal tract: a retrospective analysis of 139 cases P Katsinelos, J Kountouras, G Paroutoglou, C Zavos, K Mimidis, ... Journal of clinical gastroenterology 40 (9), 784-789, 2006 | 204 | 2006 |
| Helicobacter pylori infection in patients with nonalcoholic fatty liver disease SA Polyzos, J Kountouras, A Papatheodorou, K Patsiaoura, E Katsiki, ... Metabolism 62 (1), 121-126, 2013 | 196 | 2013 |
| Irisin: a renaissance in metabolism? SA Polyzos, J Kountouras, K Shields, CS Mantzoros Metabolism 62 (8), 1037-1044, 2013 | 192 | 2013 |
| Efficacy and safety of therapeutic ERCP in patients 90 years of age and older P Katsinelos, G Paroutoglou, J Kountouras, C Zavos, A Beltsis, ... Gastrointestinal endoscopy 63 (3), 417-423, 2006 | 183 | 2006 |